10.2 Quality Assurance Standards

10.2 Quality Assurance Standards

Quick Answer: Quality assurance means building a reliable path from order to result—preventing preanalytical errors, applying clear rejection criteria, documenting every critical step, and using trend data to improve the process. Never analyze a specimen whose identity or integrity is in doubt.

Domain II-I of the RPT outline requires you to meet quality assurance standards. Phlebotomists sit at the front of the total testing process. You are often the last person who can stop a bad specimen before it becomes a bad result that changes diagnosis, dosing, or transfusion decisions.

QA, QC, and QI—Know the Difference

These terms appear together on exams and in hospital policies. They are related but not interchangeable.

QA is the umbrella. QC verifies analytic performance; QI turns rejection logs and error rates into process fixes. Your bedside habits are QA in action even when no instrument is involved.

The Total Testing Process and Where Errors Occur

Laboratory medicine divides work into three phases:

1. Preanalytical — test ordering, patient preparation, collection, labeling, transport, accessioning, centrifugation
2. Analytical — measurement on instruments or manual methods
3. Postanalytical — result validation, reporting, critical-value notification, charting

Research and accreditation surveys consistently show that the majority of laboratory errors occur in the preanalytical phase—exactly where phlebotomists work. That is why rejection criteria feel strict: they are patient-safety tools, not bureaucratic obstacles. A hemolyzed potassium or a mislabeled tube can harm a patient even when the analyzer itself is perfectly calibrated.

Preanalytical Quality Assurance

Preanalytical QA is everything that happens before the specimen reaches the analyzer. High-yield prevention habits aligned with CLSI-style practice and facility standard operating procedures:

1. Positive patient identification every time—two unique identifiers compared to the order and wristband before every collection.
2. Match tube to test before leaving the bedside; know order of draw to limit additive carryover errors.
3. Fill coagulation (citrate) tubes to the indicator line; gentle inversion of anticoagulant tubes—never vigorous shaking that hemolyzes specimens.
4. Allow alcohol to dry; use appropriate needle gauge; avoid traumatic sticks and prolonged tourniquet time that promote hemolysis.
5. Label at the bedside immediately after collection—never pre-label empty tubes for multiple patients.
6. Start special handling at once—ice slurry, foil wrap, warm transport, timed draws documented to the minute.
7. Transport promptly with correct temperature, cushioning, and routing; do not leave specimens in hot vehicles or pneumatic tubes when policy prohibits them.
8. Educate patients on fasting, medication timing, clean-catch technique, and 24-hour urine rules so returned specimens are valid.

When something goes wrong during the draw—broken order of draw, difficult stick with probable hemolysis, patient reports tingling—document and communicate. Do not silently hope the laboratory will "figure it out."

Rejection Criteria You Must Recognize

Laboratories publish acceptance rules. Memorize the patterns that trigger automatic or routine rejection:

Identification failures (usually non-negotiable rejects)

• Unlabeled specimens
• Labels that do not match the requisition (name, MRN, or second identifier mismatch)
• Missing required identifiers when policy demands two
• Blood bank specimens missing witnessed identification elements required by transfusion services

Golden rule: If patient identity is uncertain, do not test. Recollect. Never relabel in the laboratory based on memory of who was in the room.

Integrity and container failures

• Clotted EDTA tube submitted for CBC or platelet count
• Clotted or underfilled light-blue sodium citrate tube for PT/INR, aPTT, or fibrinogen
• Gross hemolysis for potassium, LDH, AST, bilirubin, and other hemolysis-sensitive assays
• Wrong additive—for example, EDTA plasma sent for a test requiring serum
• Wrong container or missing preservative for the ordered test (O&P fixative, blood culture bottle set, etc.)
• Quantity not sufficient (QNS) for the ordered panel
• Improper temperature—warm ammonia that required ice; thawed frozen analyte; cryoglobulin specimen that was chilled
• Excessive delay beyond published stability limits
• IV-fluid contamination or specimen drawn proximal to an infusing line without proper discard protocol
• Leaking containers, needles left on syringes, or exterior contamination with biohazard risk

Some irreplaceable specimens (CSF, limited body fluids, forensic collections) may follow special medical-director pathways—but identity failures remain absolute rejects in virtually every facility.

Documentation That Supports QA

If it was not documented, the laboratory cannot defend the result in accreditation surveys, litigation, or root-cause analysis. Core documentation elements include:

• Collector identity and credentials or employee ID
• Collection date and time—exact clock times for therapeutic drug monitoring peaks/troughs, glucose tolerance intervals, and timed hormones
• Patient preparation notes—fasting status, last dose time, special diet holds
• Collection site and method when relevant—venous vs capillary; difficult stick notation
• Number of attempts when policy requires
• Transport conditions—iced, protected from light, warm pack, hand-delivered STAT
• Chain-of-custody signatures and seals for legal or forensic specimens
• Rejection reason, who was notified, time notified, and recollection status
• Critical value read-back when you participate in the notification chain

Barcode scanners and electronic order entry reduce transcription errors—only if staff scan wristbands and tubes instead of overriding alerts to save seconds. Overrides without cause are a leading QA failure in modern hospitals.

Responding to a Rejected Specimen

Professional response to rejection protects patients and supports continuous improvement:

1. Accept the rejection without arguing that "the patient is a hard stick."
2. Clarify the exact reason—QNS vs hemolysis vs labeling vs clot.
3. Notify the responsible nurse or provider promptly, especially for STAT orders or irreplaceable specimens.
4. Arrange recollection with technique changes addressing the root cause—larger vein, butterfly device, hand delivery instead of pneumatic tube, smaller-volume citrate tube for fragile veins.
5. Document the episode in the collection record or incident system so QI analysts can detect patterns.

Sending a doubtful specimen "anyway" transfers risk to the patient and the laboratory. Recollection is inconvenient; treating based on a invalid result is dangerous.

Continuous Improvement

Continuous improvement turns individual rejections into safer systems. QA committees and laboratory leadership routinely review metrics such as:

• Hemolysis rate by hospital unit, shift, and collection method
• Blood culture contamination rate
• Mislabeled specimen count
• Recollection rate and documented reasons
• Turnaround time from collection to laboratory receipt
• Pneumatic tube transport hemolysis trends
• Patient identification near-miss reports

Your role in QI is honest reporting and willingness to change technique when data show a problem. A unit with chronically hemolyzed potassium specimens may need to ban certain tubes from the pneumatic system. A clinic with frequent underfilled coagulation tubes may need low-draw citrate tubes—not pressure to "just send what you got."

Continuous improvement is not blame culture. It asks: What about our process allowed this error? Barcode policy gaps, inadequate staffing at peak draw times, missing ice slurry supplies, and unclear fasting instructions are systemic fixes—not patient faults.

A Bedside QA Mindset—Five Questions Before You Leave

Pause at the bedside and confirm:

1. Right patient? (two identifiers verified)
2. Right tests and tubes, filled correctly and mixed per additive requirements?
3. Labels complete and attached now—not later at the nurses' station?
4. Special handling started—ice, foil, warm pack, timed draw documented?
5. Transport method safe for this specimen type and priority?

That thirty-second checklist is practical quality assurance. It prevents the majority of preanalytical failures before they reach the accessioning bench.

Proficiency Testing and Delta Checks

Two analytical-phase safeguards appear on RPT items even though a phlebotomist rarely runs them.

Proficiency testing (PT) is external quality assessment: an approved program mails unknown specimens, the laboratory tests them, and the program grades the answers against peer results. Two CLIA rules matter and are heavily tested:

• PT specimens must be handled exactly like patient specimens — same personnel, same instruments, same procedures, no extra repeats, no committee discussion.
• A laboratory must never refer a PT specimen to another laboratory for testing, and never share results with another laboratory before the reporting deadline. Referral is among the most serious CLIA violations and can cost a laboratory its certificate.
• PT is required for regulated non-waived analytes. It is not required for waived tests, although accreditors often expect an alternative performance assessment.

If a courier or phlebotomist is handed a PT specimen to transport, treat it as a routine specimen and do not reroute it to a reference laboratory "to be helpful."

Delta checks compare a patient's current result to their own previous result for the same analyte. A result that swings implausibly — a hemoglobin of 14.2 g/dL yesterday and 7.8 g/dL today with no bleeding — triggers a review before release. Delta-check failures are frequently caused by preanalytical errors that belong to collection: a specimen drawn above a running IV, two patients' tubes mislabeled with each other, or a diluted draw. When the laboratory calls you about a delta-check flag, the honest answer about how the specimen was collected is far more useful than a confident guess.

Regulatory and Accreditation Context

Hospital and laboratory QA programs align with CLIA requirements, CAP or The Joint Commission laboratory standards, and OSHA safety rules. Phlebotomists demonstrate QA compliance through:

• Annual competency assessments
• Adherence to written collection procedures
• Participation in mock tracer audits and safety drills
• Correct use of personal protective equipment and sharps safety devices
• Incident reporting when near-misses occur

You do not need to memorize every accreditation standard number—but you must understand that specimen acceptance, rejection, and documentation are inspectable elements tied directly to your daily work.

Exam Focus

Expect questions that distinguish QA from QC, identify the preanalytical phase as the largest error source, select correct rejection actions for unlabeled or clotted tubes, and choose documentation elements that protect patients. The best answer always prioritizes correct identification and specimen integrity over convenience, speed, or avoiding a redraw. When identity is in doubt, recollect—never test.